Access the full text.
Sign up today, get DeepDyve free for 14 days.
O. Finn (2014)
Cancer Immunology at the Crossroads: Experimental Immunotherapies Vaccines for Cancer Prevention: A Practical and Feasible Approach to the Cancer Epidemic
S. Tas, M. Vervoordeldonk, N. Hajji, J. Schuitemaker, Koen Sluijs, M. May, S. Ghosh, M. Kapsenberg, P. Tak, E. Jong (2007)
Noncanonical NF-κB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulationBlood, 110
LA Ridnour (2013)
Molecular pathways: toll-like receptors in the tumor microenvironment–poor prognosis or new therapeutic opportunityClin Cancer Res, 19
B. Pulendran, R. Ahmed (2006)
Translating Innate Immunity into Immunological Memory: Implications for Vaccine DevelopmentCell, 124
H. Hemmi, T. Kaisho, K. Takeda, S. Akira (2003)
The Roles of Toll-Like Receptor 9, MyD88, and DNA-Dependent Protein Kinase Catalytic Subunit in the Effects of Two Distinct CpG DNAs on Dendritic Cell Subsets1The Journal of Immunology, 170
Min-jung Park, Kyung-Su Park, Hyun-Sil Park, M. Cho, Sue‐Yun Hwang, S. Min, Mi-Kyung Park, Sung-Hwan Park, Ho‐Youn Kim (2012)
A distinct tolerogenic subset of splenic IDO(+)CD11b(+) dendritic cells from orally tolerized mice is responsible for induction of systemic immune tolerance and suppression of collagen-induced arthritis.Cellular immunology, 278 1-2
J. Vasilakos, M. Tomai (2013)
The use of Toll-like receptor 7/8 agonists as vaccine adjuvantsExpert Review of Vaccines, 12
Huazhang An, Yizhi Yu, Minghui Zhang, Hongmei Xu, Runzi Qi, Xiaoyi Yan, Shuxun Liu, Wenya Wang, Zhenghong Guo, Jun Guo, Zhihai Qin, Xuetao Cao (2002)
Involvement of ERK, p38 and NF‐κB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cellsImmunology, 106
Sonja Meixlsperger, C. Leung, Patrick Rämer, M. Pack, L. Vanoaica, Gaëlle Breton, S. Pascolo, A. Salazar, A. Dzionek, J. Schmitz, R. Steinman, C. Münz (2013)
CD141+ dendritic cells produce prominent amounts of IFN-α after dsRNA recognition and can be targeted via DEC-205 in humanized mice.Blood, 121 25
Silvia Torres, Juan Hernández, Diana Giraldo, M. Arboleda, M. Rojas, J. Smit, S. Urcuqui-Inchima (2013)
Differential Expression of Toll-like Receptors in Dendritic Cells of Patients with Dengue during Early and Late Acute Phases of the DiseasePLoS Neglected Tropical Diseases, 7
L. Verinaud, L. Issayama, Fábio Zanucoli, Ana Carvalho, Thiago Costa, R. Gangi, A. Bonfanti, I. Ferreira, A. Oliveira, Dagmar Machado, R. Thome (2014)
Nitric oxide plays a key role in the suppressive activity of tolerogenic dendritic cellsCellular and Molecular Immunology, 12
M. Swiecki, M. Colonna (2015)
The multifaceted biology of plasmacytoid dendritic cellsNature Reviews Immunology, 15
K. Saikh, T. Kissner, A. Sultana, G. Ruthel, R. Ulrich (2004)
Human Monocytes Infected with Yersinia pestis Express Cell Surface TLR9 and Differentiate into Dendritic Cells1The Journal of Immunology, 173
M. Abdul-Cader, A. Amarasinghe, M. Abdul-Careem (2016)
Activation of toll-like receptor signaling pathways leading to nitric oxide-mediated antiviral responsesArchives of Virology, 161
Ana Hernandez, M. Burger, B. Blomberg, W. Ross, J. Gaynor, Inna Lindner, R. Cirocco, J. Mathew, M. Carreño, Yidi Jin, Kelvin Lee, V. Esquenazi, Joshua Miller (2007)
Inhibition of NF-kappa B during human dendritic cell differentiation generates anergy and regulatory T-cell activity for one but not two human leukocyte antigen DR mismatches.Human immunology, 68 9
T. Lang, P. Nguyen, R. Peach, W. Gause, C. Via (2002)
In Vivo CD86 Blockade Inhibits CD4+ T Cell Activation, Whereas CD80 Blockade Potentiates CD8+ T Cell Activation and CTL Effector Function1The Journal of Immunology, 168
W. Xiong, M. Candolfi, Chunyan Liu, A. Muhammad, K. Yagiz, M. Puntel, P. Moore, J. Avalos, John Young, D. Khan, R. Donelson, G. Pluhar, J. Ohlfest, K. Wawrowsky, P. Lowenstein, M. Castro (2010)
Human Flt3L Generates Dendritic Cells from Canine Peripheral Blood Precursors: Implications for a Dog Glioma Clinical TrialPLoS ONE, 5
K. Palucka, J. Banchereau (2012)
Cancer immunotherapy via dendritic cellsNature Reviews Cancer, 12
E. Itakura, Rong‐Rong Huang, D. Wen, Eberhard Paul, P. Wünsch, A. Cochran (2010)
IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competenceModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 24
Beate Berghöfer, G. Haley, Ture Frommer, G. Bein, H. Hackstein (2007)
Natural and Synthetic TLR7 Ligands Inhibit CpG-A- and CpG-C-Oligodeoxynucleotide-Induced IFN-α Production1The Journal of Immunology, 178
F. Fallarino, P. Puccetti (2006)
Toll‐like receptor 9‐mediated induction of the immunosuppressive pathway of tryptophan catabolismEuropean Journal of Immunology, 36
J Couzin-Frankel (2013)
Breakthrough of the year 2013Cancer Immunother Sci, 342
J. Marshall, D. Heeke, M. Gesner, B. Livingston, G. Nest (2007)
Negative regulation of TLR9‐mediated IFN‐α induction by a small‐molecule, synthetic TLR7 ligandJournal of Leukocyte Biology, 82
G. Napolitani, A. Rinaldi, F. Bertoni, F. Sallusto, A. Lanzavecchia (2005)
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cellsNature Immunology, 6
H. Xiong, Chen Zhu, Fengling Li, R. Hegazi, Kaili He, M. Babyatsky, A. Bauer, S. Plevy (2004)
Inhibition of Interleukin-12 p40 Transcription and NF-κB Activation by Nitric Oxide in Murine Macrophages and Dendritic Cells*Journal of Biological Chemistry, 279
T. Mogensen (2009)
Pathogen Recognition and Inflammatory Signaling in Innate Immune DefensesClinical Microbiology Reviews, 22
M. Dey, Alan Chang, J. Miska, D. Wainwright, Atique Ahmed, I. Balyasnikova, P. Pytel, Yu Han, Alex Tobias, Lingjiao Zhang, J. Qiao, M. Lesniak (2015)
Dendritic Cell–Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant GliomaThe Journal of Immunology, 195
V. Hornung, S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdörfer, T. Giese, S. Endres, G. Hartmann (2002)
Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1The Journal of Immunology, 168
Jianping Pan, Minghui Zhang, Jianli Wang, Qingqing Wang, D. Xia, Wenji Sun, Lihuang Zhang, Hai Yu, Yong‐jun Liu, Xuetao Cao (2004)
Interferon-γ is an autocrine mediator for dendritic cell maturationImmunology Letters, 94
A. Bagchi, Elizabeth Herrup, H. Warren, James Trigilio, Hae-sook Shin, Catherine Valentine, J. Hellman (2007)
MyD88-Dependent and MyD88-Independent Pathways in Synergy, Priming, and Tolerance between TLR Agonists1The Journal of Immunology, 178
Alexandre Larangé, D. Antonios, M. Pallardy, S. Kerdine-Römer (2009)
TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturationJournal of Leukocyte Biology, 85
S. Akira, K. Takeda (2004)
Toll-like receptor signallingNature Reviews Immunology, 4
C. Zent, Brian Smith, Z. Ballas, J. Wooldridge, B. Link, T. Call, T. Shanafelt, D. Bowen, N. Kay, T. Witzig, G. Weiner (2012)
Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemiaLeukemia & Lymphoma, 53
L. Ridnour, R. Cheng, C. Switzer, Julie Heinecke, S. Ambs, S. Glynn, H. Young, G. Trinchieri, D. Wink (2013)
Molecular Pathways Molecular Pathways : Toll-like Receptors in the Tumor Microenvironment — Poor Prognosis or New Therapeutic Opportunity
Julia Scheiermann, D. Klinman (2014)
Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer.Vaccine, 32 48
B. Hoesel, J. Schmid (2013)
The complexity of NF-κB signaling in inflammation and cancerMolecular Cancer, 12
V. Athié-Morales, H. Smits, D. Cantrell, C. Hilkens (2004)
Sustained IL-12 Signaling Is Required for Th1 Development 1The Journal of Immunology, 172
S. Hontelez, M. Ansems, N. Karthaus, Malou Zuidscherwoude, M. Looman, V. Triantis, G. Adema (2012)
Dendritic Cell-Specific Transcript: Dendritic Cell Marker and Regulator of TLR-Induced Cytokine ProductionThe Journal of Immunology, 189
J. Booth, J. Buza, A. Potter, L. Babiuk, G. Mutwiri (2010)
Co-stimulation with TLR7/8 and TLR9 agonists induce down-regulation of innate immune responses in sheep blood mononuclear and B cells.Developmental and comparative immunology, 34 5
F. Sallusto, A. Lanzavecchia (1994)
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alphaThe Journal of Experimental Medicine, 179
Xiufen Zheng, J. Koropatnick, Di Chen, T. Velenosi, H. Ling, Xusheng Zhang, Nan Jiang, Benjamin Navarro, T. Ichim, B. Urquhart, W. Min (2013)
Silencing IDO in dendritic cells: A novel approach to enhance cancer immunotherapy in a murine breast cancer modelInternational Journal of Cancer, 132
O. Markov, N. Mironova, S. Sennikov, V. Vlassov, M. Zenkova (2015)
Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic MelanomaPLoS ONE, 10
A. Krug, S. Rothenfusser, S. Selinger, C. Bock, M. Kerkmann, J. Battiany, A. Sarris, T. Giese, D. Speiser, S. Endres, G. Hartmann (2003)
CpG-A Oligonucleotides Induce a Monocyte-Derived Dendritic Cell-Like Phenotype That Preferentially Activates CD8 T Cells1The Journal of Immunology, 170
Delia Ramírez, Julieta Saba, Lila Carniglia, D. Durand, M. Lasaga, Carla Caruso (2015)
Melanocortin 4 receptor activates ERK-cFos pathway to increase brain-derived neurotrophic factor expression in rat astrocytes and hypothalamusMolecular and Cellular Endocrinology, 411
Soledad Keon, M. Ruiz, S. Gazzaniga, R. Wainstok (2015)
Dendritic Cell-Based Vaccination in Cancer: Therapeutic Implications Emerging from Murine ModelsFrontiers in Immunology, 6
D. Klinman (2004)
Immunotherapeutic uses of CpG oligodeoxynucleotidesNature Reviews Immunology, 4
Jie Yang, Yiming Yang, H. Fan, H. Zou (2014)
Tolerogenic Splenic IDO+ Dendritic Cells from the Mice Treated with Induced-Treg Cells Suppress Collagen-Induced ArthritisJournal of Immunology Research, 2014
R. Semnani, P. Venugopal, C. Leifer, S. Mostböck, H. Sabzevari, T. Nutman (2008)
Inhibition of TLR3 and TLR4 function and expression in human dendritic cells by helminth parasites.Blood, 112 4
S. Behboudi, D. Chao, P. Klenerman, J. Austyn (1998)
The effects of DNA containing CpG motif on dendritic cellsImmunology, 99
W. Strober (2001)
Trypan Blue Exclusion Test of Cell ViabilityCurrent Protocols in Immunology, 111
R. Sabado, N. Bhardwaj (2015)
Cancer immunotherapy: Dendritic-cell vaccines on the moveNature, 519
P. Puccetti, U. Grohmann (2007)
IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-κB activationNature Reviews Immunology, 7
S. Kaczanowska, A. Joseph, E. Davila (2013)
TLR agonists: our best frenemy in cancer immunotherapyJournal of Leukocyte Biology, 93
Katherine Upchurch, José Boquín, Wenjie Yin, Yaming Xue, HyeMee Joo, R. Kane, SangKon Oh (2015)
New TLR7 agonists with improved humoral and cellular immune responses.Immunology letters, 168 1
C. Aslakson, F. Miller (1992)
Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor.Cancer research, 52 6
OJ Finn (2014)
Vaccines for cancer prevention: a practical and feasible approach to the cancer epidemicCancer Immunol Res, 2
B. Zhao, J. Vasilakos, Debra Tross, D. Smirnov, D. Klinman (2014)
Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumorsJournal for Immunotherapy of Cancer, 2
N. Butchi, M. Du, K. Peterson (2009)
Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microgliaGlia, 58
V. Lombardi, L. Overtvelt, S. Horiot, P. Moingeon (2009)
Human Dendritic Cells Stimulated via TLR7 and/or TLR8 Induce the Sequential Production of Il-10, IFN-γ, and IL-17A by Naive CD4+ T CellsThe Journal of Immunology, 182
Bo Huang, J. Zhao, J. Unkeless, Z. Feng, H. Xiong (2008)
TLR signaling by tumor and immune cells: a double-edged swordOncogene, 27
Craig Platt, Jessica Ma, Cecile Chalouni, Melanie Ebersold, H. Bou-Reslan, R. Carano, I. Mellman, L. Delamarre (2010)
Mature dendritic cells use endocytic receptors to capture and present antigensProceedings of the National Academy of Sciences, 107
A. Broad, J. Kirby, David Jones (2007)
Toll‐like receptor interactions: tolerance of MyD88‐dependent cytokines but enhancement of MyD88‐independent interferon‐β productionImmunology, 120
M. Degli-Esposti, M. Smyth (2005)
Close encounters of different kinds: Dendritic cells and NK cells take centre stageNature Reviews Immunology, 5
Tomoki Ito, R. Amakawa, T. Kaisho, H. Hemmi, K. Tajima, K. Uehira, Y. Ozaki, H. Tomizawa, S. Akira, S. Fukuhara (2002)
Interferon-α and Interleukin-12 Are Induced Differentially by Toll-like Receptor 7 Ligands in Human Blood Dendritic Cell SubsetsThe Journal of Experimental Medicine, 195
S. Bauer, C. Kirschning, H. Häcker, V. Redecke, S. Hausmann, S. Akira, H. Wagner, G. Lipford (2001)
Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognitionProceedings of the National Academy of Sciences of the United States of America, 98
C. Bode, Gan Zhao, F. Steinhagen, T. Kinjo, D. Klinman (2003)
CpG DNA as a vaccine adjuvantExpert Review of Vaccines, 10
Peter Hellman, H. Eriksson (2007)
Early activation markers of human peripheral dendritic cells.Human immunology, 68 5
J. Pufnock, Melinda Cigal, Lisa Rolczynski, E. Andersen-Nissen, Mathias Wolfl, M. McElrath, P. Greenberg (2011)
Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28.Blood, 117 24
R. Flores, K. Diggs, L. Tait, P. Morel (2007)
IFN-γ Negatively Regulates CpG-Induced IL-10 in Bone Marrow-Derived Dendritic Cells1The Journal of Immunology, 178
C. Obregón, L. Graf, K. Chung, V. Cesson, L. Nicod (2015)
Nitric Oxide Sustains IL-1β Expression in Human Dendritic Cells Enhancing Their Capacity to Induce IL-17–Producing T-CellsPLoS ONE, 10
J. Couzin-Frankel (2013)
Breakthrough of the year 2013. Cancer immunotherapy.Science, 342 6165
S. Stier, C. Maletzki, Ulrike Klier, M. Linnebacher (2013)
Combinations of TLR Ligands: A Promising Approach in Cancer ImmunotherapyClinical and Developmental Immunology, 2013
KJ Livak, TD Schmittgen (2001)
Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT methodMethods, 25
H. Shirota, Debra Tross, D. Klinman (2015)
CpG Oligonucleotides as Cancer Vaccine AdjuvantsVaccines, 3
Qing Zhu, C. Egelston, A. Vivekanandhan, S. Uematsu, S. Akira, D. Klinman, I. Belyakov, J. Berzofsky (2008)
Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: Implications for vaccinesProceedings of the National Academy of Sciences, 105
Hiroyasu Ito, T. Ando, Y. Arioka, Kuniaki Saito, M. Seishima (2015)
Inhibition of indoleamine 2,3‐dioxygenase activity enhances the anti‐tumour effects of a Toll‐like receptor 7 agonist in an established cancer modelImmunology, 144
D. Vremec, Meredith O'Keeffe, H. Hochrein, M. Fuchsberger, I. Caminschi, M. Lahoud, K. Shortman (2007)
Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells.Blood, 109 3
M. Ciorba, Ellen Bettonville, Keely McDonald, R. Metz, G. Prendergast, R. Newberry, W. Stenson (2010)
Induction of IDO-1 by Immunostimulatory DNA Limits Severity of Experimental ColitisThe Journal of Immunology, 184
E. Smits, P. Ponsaerts, Z. Berneman, V. Tendeloo (2008)
The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy.The oncologist, 13 8
M. Schön, M. Schön (2008)
TLR7 and TLR8 as targets in cancer therapyOncogene, 27
M. Saraiva, A. O’Garra (2010)
The regulation of IL-10 production by immune cellsNature Reviews Immunology, 10
A. Paone, Donatella Starace, R. Galli, F. Padula, P. Cesaris, A. Filippini, E. Ziparo, A. Riccioli (2008)
Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism.Carcinogenesis, 29 7
P. Narayanan, N. Lapteva, Mamatha Seethammagari, J. Levitt, K. Slawin, D. Spencer (2011)
A composite MyD88/CD40 switch synergistically activates mouse and human dendritic cells for enhanced antitumor efficacy.The Journal of clinical investigation, 121 4
Gerhard Wingender, N. Garbi, B. Schumak, F. Jüngerkes, E. Endl, Dagmar von Bubnoff, J. Steitz, Jörg Striegler, G. Moldenhauer, T. Tüting, A. Heit, K. Huster, O. Takikawa, S. Akira, D. Busch, H. Wagner, G. Hämmerling, P. Knolle, A. Limmer (2006)
Systemic application of CpG‐rich DNA suppresses adaptive T cell immunity via induction of IDOEuropean Journal of Immunology, 36
C. Paolucci, S. Burastero, P. Rovere-Querini, C. Palma, S. Falcone, C. Perrotta, A. Capobianco, A. Manfredi, E. Clementi (2003)
Synergism of nitric oxide and maturation signals on human dendritic cells occurs through a cyclic GMP‐dependent pathwayJournal of Leukocyte Biology, 73
T. Kawai, S. Akira (2007)
Signaling to NF-?B by Toll-like receptorsTrends in Molecular Medicine
K. Livak, Thomas Schmittgen (2001)
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.Methods, 25 4
P. Utaisincharoen, N. Anuntagool, P. Chaisuriya, S. Pichyangkul, S. Sirisinha (2002)
CpG ODN activates NO and iNOS production in mouse macrophage cell line (RAW 264·7)Clinical & Experimental Immunology, 128
K. Rosenberger, K. Derkow, Paul Dembny, C. Krüger, E. Schott, S. Lehnardt (2014)
The impact of single and pairwise Toll-like receptor activation on neuroinflammation and neurodegenerationJournal of Neuroinflammation, 11
H. Hemmi, T. Kaisho, O. Takeuchi, Shintaro Sato, H. Sanjo, K. Hoshino, T. Horiuchi, H. Tomizawa, K. Takeda, S. Akira (2002)
Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathwayNature Immunology, 3
B. Baban, P. Chandler, Burles Johnson, Lei Huang, Minghui Li, Marlon Sharpe, Loise Francisco, A. Sharpe, B. Blazar, D. Munn, A. Mellor (2011)
Physiologic Control of IDO Competence in Splenic Dendritic CellsThe Journal of Immunology, 187
I. Hirsch, C. Caux, U. Hasan, N. Bendriss-Vermare, D. Olive (2010)
Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer.Trends in immunology, 31 10
D. Mitchell, M. Yong, W. Schroder, Matthew Black, M. Tirrell, C. Olive (2010)
Dual stimulation of MyD88-dependent Toll-like receptors induces synergistically enhanced production of inflammatory cytokines in murine bone marrow-derived dendritic cells.The Journal of infectious diseases, 202 2
A. Krieg (2008)
Toll-like receptor 9 (TLR9) agonists in the treatment of cancerOncogene, 27
C. Bogdan (2001)
Nitric oxide and the immune responseNature Immunology, 2
C. Hémont, A. Néel, M. Heslan, C. Braudeau, R. Josien (2013)
Human blood mDC subsets exhibit distinct TLR repertoire and responsivenessJournal of Leukocyte Biology, 93
A. Mellor, B. Baban, P. Chandler, Anna Manlapat, David Kahler, D. Munn (2005)
Cutting Edge: CpG Oligonucleotides Induce Splenic CD19+ Dendritic Cells to Acquire Potent Indoleamine 2,3-Dioxygenase-Dependent T Cell Regulatory Functions via IFN Type 1 Signaling1The Journal of Immunology, 175
C. Montoya, C. Montoya, H. Jie, L. Al-Harthi, Candice Mulder, P. Patiño, M. Rugeles, A. Krieg, A. Landay, S. Wilson (2006)
Activation of Plasmacytoid Dendritic Cells with TLR9 Agonists Initiates Invariant NKT Cell-Mediated Cross-Talk with Myeloid Dendritic Cells1The Journal of Immunology, 177
M. Plattén, Nikolaus Doeberitz, I. Oezen, W. Wick, K. Ochs (2015)
Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream EffectorsFrontiers in Immunology, 5
R. Samarasinghe, Prafullakumar Tailor, T. Tamura, T. Kaisho, S. Akira, K. Ozato (2006)
Induction of an anti-inflammatory cytokine, IL-10, in dendritic cells after toll-like receptor signaling.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 26 12
Rui Wang, Meng Lu, Jie Zhang, Sufeng Chen, Xiao-yang Luo, Ying Qin, Haiquan Chen (2011)
Increased IL-10 mRNA expression in tumor-associated macrophage correlated with late stage of lung cancerJournal of Experimental & Clinical Cancer Research : CR, 30
J. Rodríguez, José Marchicio, Mariela López, A. Ziblat, F. Elías, J. Fló, R. López, D. Horn, J. Zorzópulos, A. Montaner (2015)
PyNTTTTGT and CpG Immunostimulatory Oligonucleotides: Effect on Granulocyte/Monocyte Colony-Stimulating Factor (GM-CSF) Secretion by Human CD56+ (NK and NKT) CellsPLoS ONE, 10
MS Abdul-Cader, A Amarasinghe, MF Abdul-Careem (2016)
Activation of toll-like receptor signaling pathways leading to nitric oxide-mediated antiviral responsesAdv Virol, 161
M. Ligtenberg, Nicole Rojas-Colonelli, R. Kiessling, A. Lladser (2013)
NF-κB activation during intradermal DNA vaccination is essential for eliciting tumor protective antigen-specific CTL responsesHuman Vaccines & Immunotherapeutics, 9
M. Hayden, S. Ghosh (2011)
NF-κB in immunobiologyCell Research, 21
C. Bourquin, C. Hotz, D. Noerenberg, A. Voelkl, S. Heidegger, Laurin Roetzer, Bettina Storch, N. Sandholzer, Cornelia Wurzenberger, D. Anz, S. Endres (2011)
Systemic cancer therapy with a small molecule agonist of toll-like receptor 7 can be improved by circumventing TLR tolerance.Cancer research, 71 15
V. Hoene, M. Peiser, R. Wanner (2006)
Human monocyte‐derived dendritic cells express TLR9 and react directly to the CpG‐A oligonucleotide D19Journal of Leukocyte Biology, 80
F. Aktan (2004)
iNOS-mediated nitric oxide production and its regulation.Life sciences, 75 6
T. Akazawa, M. Shingai, Miwa Sasai, T. Ebihara, N. Inoue, M. Matsumoto, T. Seya (2007)
Tumor immunotherapy using bone marrow‐derived dendritic cells overexpressing Toll‐like receptor adaptorsFEBS Letters, 581
M. Sioud, S. Saebøe-Larssen, T. Hetland, J. Kaern, Anne Mobergslien, G. Kvalheim (2013)
Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients.International journal of oncology, 43 1
G. Trinchieri, A. Sher (2007)
Cooperation of Toll-like receptor signals in innate immune defenceNature Reviews Immunology, 7
Hua Wang, Hui Xu, W. Lu, Lin Zhu, Yunhai Yu, Fan-zhen Hong (2013)
In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancerArchives of Gynecology and Obstetrics, 289
H. Adler, Alexandra Simon, Edith Graulich, A. Habermeier, N. Bacher, A. Friebe, E. Closs, K. Steinbrink (2010)
Neuronal Nitric Oxide Synthase Modulates Maturation of Human Dendritic CellsThe Journal of Immunology, 184
M. Ahn, Seong-Min Kwon, H. Cheong, Jong-Hwan Park, J. Lee, S. Min, Sang‐Gun Ahn, J. Yoon (2012)
Toll-like receptor 7 agonist, imiquimod, inhibits oral squamous carcinoma cells through apoptosis and necrosis.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 41 7
D. Jarrossay, G. Napolitani, M. Colonna, F. Sallusto, A. Lanzavecchia (2001)
Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cellsEuropean Journal of Immunology, 31
A. Urtreger, V. Ladeda, L. Puricelli, A. Rivelli, M. Vidal, E. Delustig, E. Joffe (1997)
Modulation of fibronectin expression and proteolytic activity associated with the invasive and metastatic phenotype in two new murine mammary tumor cell lines.International journal of oncology, 11 3
M. Candolfi, G. King, K. Yagiz, James Curtin, Y. Mineharu, A. Muhammad, D. Foulad, K. Kroeger, N. Barnett, R. Josien, P. Lowenstein, M. Castro (2012)
Plasmacytoid dendritic cells in the tumor microenvironment: immune targets for glioma therapeutics.Neoplasia, 14 8
Deyan Hou, A. Muller, Madhav Sharma, J. DuHadaway, Tinku Banerjee, Maribeth Johnson, A. Mellor, G. Prendergast, D. Munn (2007)
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.Cancer research, 67 2
J Cancer Res Clin Oncol (2017) 143:1713–1732 DOI 10.1007/s00432-017-2421-7 ORIGINAL ARTICLE – CANCER RESEARCH Dual activation of Toll‑like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer 1 1,2 3 1 Mariela A. Moreno Ayala · María Florencia Gottardo · María Soledad Gori · Alejandro Javier Nicola Candia · 1,2 4,5 1 6 2,6 Carla Caruso · Andrea De Laurentiis · Mercedes Imsen · Slobodanka Klein · Elisa Bal de Kier Joffé · 3,7 8,9 1,2 1 Gabriela Salamone · Maria G. Castro · Adriana Seilicovich · Marianela Candolfi Received: 30 April 2016 / Accepted: 8 April 2017 / Published online: 21 April 2017 © Springer-Verlag Berlin Heidelberg 2017 Abstract simultaneously activated. Blockade of nitric oxide synthase Purpose Since combination of Toll-like receptor (TLR) (NOS) and indoleamine-pyrrole-2,3-dioxygenase (IDO) ligands could boost antitumor immunity, we evaluated the improved the activation of CpG-DCs. When we evaluated efficacy of dendritic cell (DC) vaccines upon dual activa - the effect of combined activation of TLR9 and TLR7 in tion of TLR9 and TLR7 in breast cancer models. human DCs, we found that R848 induced robust DC activa- Methods DCs were generated from mouse bone marrow
Journal of Cancer Research and Clinical Oncology – Springer Journals
Published: Apr 21, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.